Nomura Holdings
ABUS icon

Nomura Holdings’s Arbutus Biopharma ABUS Stock Holding History

Nomura Holdings’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-150,000
Closed -$722K – 1665
2025
Q4 		$722K Hold
150,000
– – ﹤0.01% 1431
2025
Q3 		$681K Buy
150,000
+50,000
+50% +$184K ﹤0.01% 1521
2025
Q2 		$309K Hold
100,000
– – ﹤0.01% 1232
2025
Q1 		$349K Buy
+100,000
New +$333K ﹤0.01% 1571

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Nomura Holdings's ABUS Position: Q1 2026 in Review

Nomura Holdings sold out of Arbutus Biopharma (ABUS) in Q1 2026, closing a stake of 98,100 shares — an estimated $472K sold.

Nomura Holdings first reported a position in ABUS in Q2 2014 and held it in 6 quarters. The position peaked at $777K in Q2 2014. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • Nomura Holdings reported no remaining Arbutus Biopharma position as of Q1 2026 after selling out during the quarter.
  • Nomura Holdings sold 98,100 Arbutus Biopharma shares in Q1 2026, an estimated $472K.
  • Nomura Holdings first reported a position in Arbutus Biopharma in Q2 2014 and held it in 6 quarters.
  • Nomura Holdings's Arbutus Biopharma position peaked at $777K in Q2 2014.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.